Bosutris 400 mg Tablets Bosutris 400 mg Tablets contain bosutinib, a targeted anticancer medicine used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML). It works by blocking abnormal tyrosine kinase enzymes that encourage the growth and survival of leukemia cells. By stopping these signals, the medicine helps control the disease, reduce the number of abnormal blood cells, and slow the progression of leukemia.

Effects & Benefits Helps control the growth of leukemia cells. Used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Reduces the production of abnormal white blood cells. Helps slow disease progression and maintain treatment response. May improve long-term disease control when taken as prescribed. Supports effective management of leukemia under specialist care. Possible Side Effects

Like all medicines, Bosutris 400 mg Tablets may cause side effects, although not everyone experiences them